Pricing
Login
Home
Charts
Search
Watchlist
Products

Ipca Laboratories Ltd

IPCALAB
₹1,843.80-0.87%20 Nov 2026
Reports
Pharma Formulations

Ipca Laboratories Ltd

IPCALAB
₹1,843.80
-0.87%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹46,778Cr
Close
Close Price
₹1,843.80
Industry
Industry
Pharma Formulations
PE
Price To Earnings
32.46
PS
Price To Sales
4.46
Revenue
Revenue
₹10,479Cr
Rev Gr TTM
Revenue Growth TTM
11.99%
PAT Gr TTM
PAT Growth TTM
72.79%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,0532,0332,0932,3552,2452,2472,3092,5572,3932,3882,7882,910
Growth YoY
Revenue Growth YoY%
32.834.532.015.89.410.510.38.66.56.320.813.8
Expenses
ExpensesCr
1,7221,7111,7001,9131,7821,8181,8922,0121,8591,9052,1192,236
Operating Profit
Operating ProfitCr
331322393441463429416545533484670673
OPM
OPM%
16.115.818.818.820.619.118.021.322.320.324.023.1
Other Income
Other IncomeCr
91-118212620-17933-303848251
Interest Expense
Interest ExpenseCr
332924231722192018201213
Depreciation
DepreciationCr
100989910098100100103108107111115
PBT
PBTCr
28977290345368128331392446404572547
Tax
TaxCr
667491999162961088295149156
PAT
PATCr
223319924527766234284364309423392
Growth YoY
PAT Growth YoY%
92.6-96.419.778.624.62,160.517.815.531.3370.480.438.1
NPM
NPM%
10.80.19.510.412.32.910.211.115.212.915.213.5
EPS
EPS₹
7.12.47.69.19.82.79.211.112.913.315.814.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
2,0532,0332,0932,3552,2452,2472,3092,5572,3932,3882,7882,910
Growth YoY
Revenue Growth YoY%
32.834.532.015.89.410.510.38.66.56.320.813.8
Expenses
ExpensesCr
1,7221,7111,7001,9131,7821,8181,8922,0121,8591,9052,1192,236
Operating Profit
Operating ProfitCr
331322393441463429416545533484670673
OPM
OPM%
16.115.818.818.820.619.118.021.322.320.324.023.1
Other Income
Other IncomeCr
91-118212620-17933-303848251
Interest Expense
Interest ExpenseCr
332924231722192018201213
Depreciation
DepreciationCr
100989910098100100103108107111115
PBT
PBTCr
28977290345368128331392446404572547
Tax
TaxCr
667491999162961088295149156
PAT
PATCr
223319924527766234284364309423392
Growth YoY
PAT Growth YoY%
92.6-96.419.778.624.62,160.517.815.531.3370.480.438.1
NPM
NPM%
10.80.19.510.412.32.910.211.115.212.915.213.5
EPS
EPS₹
7.12.47.69.19.82.79.211.112.913.315.814.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,8673,1563,2583,7464,6195,4205,8306,2447,7058,9409,64610,479
Growth
Revenue Growth%
-8.810.13.215.023.317.37.67.123.416.07.912.0
Expenses
ExpensesCr
2,5782,7102,8033,0543,7123,8764,5215,3186,3847,2137,6688,119
Operating Profit
Operating ProfitCr
2904464556929071,5441,3099271,3211,7261,9792,360
OPM
OPM%
10.114.114.018.519.628.522.514.817.119.320.522.5
Other Income
Other IncomeCr
2213385659636712617-11288112
Interest Expense
Interest ExpenseCr
32242419179846138857662
Depreciation
DepreciationCr
163173178182211209232262357398418440
PBT
PBTCr
1172622915467391,3891,1367458431,1311,5731,970
Tax
TaxCr
206851104135240225253313344381482
PAT
PATCr
961952394426041,1499114925297881,1911,488
Growth
PAT Growth%
-62.9102.223.184.736.590.3-20.7-46.07.648.851.372.8
NPM
NPM%
3.46.27.311.813.121.215.67.96.98.812.314.2
EPS
EPS₹
3.77.79.517.523.945.034.918.621.629.145.056.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2,8673,1563,2583,7464,6195,4205,8306,2447,7058,9409,64610,479
Growth
Revenue Growth%
-8.810.13.215.023.317.37.67.123.416.07.912.0
Expenses
ExpensesCr
2,5782,7102,8033,0543,7123,8764,5215,3186,3847,2137,6688,119
Operating Profit
Operating ProfitCr
2904464556929071,5441,3099271,3211,7261,9792,360
OPM
OPM%
10.114.114.018.519.628.522.514.817.119.320.522.5
Other Income
Other IncomeCr
2213385659636712617-11288112
Interest Expense
Interest ExpenseCr
32242419179846138857662
Depreciation
DepreciationCr
163173178182211209232262357398418440
PBT
PBTCr
1172622915467391,3891,1367458431,1311,5731,970
Tax
TaxCr
206851104135240225253313344381482
PAT
PATCr
961952394426041,1499114925297881,1911,488
Growth
PAT Growth%
-62.9102.223.184.736.590.3-20.7-46.07.648.851.372.8
NPM
NPM%
3.46.27.311.813.121.215.67.96.98.812.314.2
EPS
EPS₹
3.77.79.517.523.945.034.918.621.629.145.056.8
Sales CAGR
1 Year8%
3 Years16%
5 Years12%
TTM12%
EBITDA CAGR
1 Year15%
3 Years29%
5 Years5%
TTM27%
PAT CAGR
1 Year51%
3 Years34%
5 Years1%
TTM73%
Avg. ROCE
1 Year19%
3 Years15%
5 Years15%
TTM22%
CFO / EBITDA
1 Year58%
3 Years68%
5 Years70%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
252525252525252525252525
Reserves
ReservesCr
2,2342,4302,6633,0973,5904,6765,4675,8176,3076,9238,0388,653
Current Liabilities
Current LiabilitiesCr
9709561,0081,0981,3261,1611,4661,8062,3562,3862,3072,407
Non Current Liabilities
Non Current LiabilitiesCr
6635484213152921926049051,019986539552
Total Liabilities
Total LiabilitiesCr
3,8923,9604,1174,5515,2606,0687,6398,62611,10111,76112,37013,133
Current Assets
Current AssetsCr
1,6221,7421,9452,3782,8563,4374,4475,1895,5365,9676,3746,924
Non Current Assets
Non Current AssetsCr
2,2702,2182,1722,1732,4042,6313,1923,4375,5665,7945,9976,206
Total Assets
Total AssetsCr
3,8923,9604,1174,5515,2606,0687,6398,62611,10111,76112,37013,133
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
252525252525252525252525
Reserves
ReservesCr
2,2342,4302,6633,0973,5904,6765,4675,8176,3076,9238,0388,653
Current Liabilities
Current LiabilitiesCr
9709561,0081,0981,3261,1611,4661,8062,3562,3862,3072,407
Non Current Liabilities
Non Current LiabilitiesCr
6635484213152921926049051,019986539552
Total Liabilities
Total LiabilitiesCr
3,8923,9604,1174,5515,2606,0687,6398,62611,10111,76112,37013,133
Current Assets
Current AssetsCr
1,6221,7421,9452,3782,8563,4374,4475,1895,5365,9676,3746,924
Non Current Assets
Non Current AssetsCr
2,2702,2182,1722,1732,4042,6313,1923,4375,5665,7945,9976,206
Total Assets
Total AssetsCr
3,8923,9604,1174,5515,2606,0687,6398,62611,10111,76112,37013,133

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7092823415015701,0908568069451,3211,142
Investing Cash Flow
Investing Cash FlowCr
-218-149-135-165-510-521-855-725-1,292-870-247
Financing Cash Flow
Financing Cash FlowCr
-462-159-130-183-137-306427507-553-283-754
Net Cash Flow
Net Cash FlowCr
29-2675153-76264428588-900169142
Free Cash Flow
Free Cash FlowCr
463147206322277731380347543551486
CFO To PAT
CFO To PAT%
736.6144.9142.5113.394.594.994.0163.8178.5167.895.8
CFO To EBITDA
CFO To EBITDA%
244.763.275.072.462.970.665.487.071.576.557.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7092823415015701,0908568069451,3211,142
Investing Cash Flow
Investing Cash FlowCr
-218-149-135-165-510-521-855-725-1,292-870-247
Financing Cash Flow
Financing Cash FlowCr
-462-159-130-183-137-306427507-553-283-754
Net Cash Flow
Net Cash FlowCr
29-2675153-76264428588-900169142
Free Cash Flow
Free Cash FlowCr
463147206322277731380347543551486
CFO To PAT
CFO To PAT%
736.6144.9142.5113.394.594.994.0163.8178.5167.895.8
CFO To EBITDA
CFO To EBITDA%
244.763.275.072.462.970.665.487.071.576.557.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,3167,8678,26512,41517,53924,13726,92220,55831,41538,08940,66946,778
Price To Earnings
Price To Earnings
78.640.434.527.928.921.230.443.657.451.635.632.5
Price To Sales
Price To Sales
2.52.52.53.33.84.54.63.34.14.34.24.5
Price To Book
Price To Book
3.23.23.14.04.85.14.93.55.05.55.05.4
EV To EBITDA
EV To EBITDA
27.018.718.918.019.615.620.721.824.622.720.720.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.355.556.057.555.459.856.350.753.455.958.358.3
OPM
OPM%
10.114.114.018.519.628.522.514.817.119.320.522.5
NPM
NPM%
3.46.27.311.813.121.215.67.96.98.812.314.2
ROCE
ROCE%
5.19.69.916.318.728.118.110.812.614.618.621.8
ROE
ROE%
4.37.98.914.216.724.416.68.48.411.314.817.1
ROA
ROA%
2.54.95.89.711.518.911.95.74.86.79.611.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7,3167,8678,26512,41517,53924,13726,92220,55831,41538,08940,66946,778
Price To Earnings
Price To Earnings
78.640.434.527.928.921.230.443.657.451.635.632.5
Price To Sales
Price To Sales
2.52.52.53.33.84.54.63.34.14.34.24.5
Price To Book
Price To Book
3.23.23.14.04.85.14.93.55.05.55.05.4
EV To EBITDA
EV To EBITDA
27.018.718.918.019.615.620.721.824.622.720.720.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
53.355.556.057.555.459.856.350.753.455.958.358.3
OPM
OPM%
10.114.114.018.519.628.522.514.817.119.320.522.5
NPM
NPM%
3.46.27.311.813.121.215.67.96.98.812.314.2
ROCE
ROCE%
5.19.69.916.318.728.118.110.812.614.618.621.8
ROE
ROE%
4.37.98.914.216.724.416.68.48.411.314.817.1
ROA
ROA%
2.54.95.89.711.518.911.95.74.86.79.611.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr61,99459,38654,98146,77844,35141,45838,677
Close PriceClose₹5,185.00364.403,331.901,843.802,337.803,317.702,408.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE29.98121.8744.4432.4640.5432.8253.22
Price To SalesPS3.973.417.774.464.336.679.32
RevenueRevenueCr15,63217,4157,07210,47910,2346,2174,148
Revenue Growth TTMRev Gr TTM%12.5%5.7%21.9%12.0%21.1%25.0%5.9%
PAT Growth TTMPAT Gr TTM%-13.2%-55.4%56.4%72.8%33.3%29.7%7.6%
Market CapitalizationMkt CapCr61,99459,38654,98146,77844,35141,45838,677
Close PriceClose₹5,185.00364.403,331.901,843.802,337.803,317.702,408.90
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE29.98121.8744.4432.4640.5432.8253.22
Price To SalesPS3.973.417.774.464.336.679.32
RevenueRevenueCr15,63217,4157,07210,47910,2346,2174,148
Revenue Growth TTMRev Gr TTM%12.5%5.7%21.9%12.0%21.1%25.0%5.9%
PAT Growth TTMPAT Gr TTM%-13.2%-55.4%56.4%72.8%33.3%29.7%7.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Interviews